This Drug DELIVERY Specific Seminar will feature Dr. Joanna Burdette of the University of Illinois Chicago: "Imaging and Microfluidic Technology to Study High Grade Serous Cancer"

This Drug DISCOVERY Specific Seminar will feature Dr. Craig Lindsley of Vanderbilt University: "Novel Therapeutic Approaches to Target Movement Disorders: Discovery to Clinic"

Dr. Zhang will discuss the biological functionalization of polymeric nanoparticles with a layer of membrane coating derived from natural cells, focusing on the use of these cell-mimicking nanoparticles for the treatment of bacterial and viral infections.

The Natural Products Discovery Center (NPDC) at UF Scripps Biomedical Research houses one of the world’s largest actinobacterial strain collections, totaling ~125,000 strains.  These strains, isolated over the last eight decades and from 69 different countries, encode natural product chemical and biological diversity that are impossible to reproduce in laboratory settings today. Professor Shen will talk about his group's efforts to launch a large-scale genome sequencing campaign to establish the Natural Products Genomics Resource Center (NPGRC) at NPDC. The sequenced genomes will be used to create the NPGRC database, which, together with the strains, will be made available to the scientific community to enable natural product studies and drug discovery.

This Drug ACTION Specific Seminar will feature Dr. Oren Becher of Icahn School of Medicine at Mount Sinai: "Diffuse Midline Glioma - Which therapeutic targets are relevant?"